Clinical trial: Cohort Study on Neuroimmune Diseases in the Reproductive Age
Clinical trial: Cohort Study on Neuroimmune Diseases in the Reproductive Age
Clinical trial: Randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to teriflunomide in adult participants with relapsing forms of multiple sclerosis
Clinical trial: Active and Mindful - A Mind-Body Programme for People With Multiple Sclerosis: a Feasibility Study Protocol
Clinical trial: Effect of High-Intensity Focused Electromagnetic Technology on Balance and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Clinical trial: PRIMUS a Multi-centre, Controlled, Cluster-randomised, Open Study of Multiple Impacts of CDSS Use in Multiple Sclerosis : Real World Usage for Real World Evidence
Clinical trial: Relationship Between Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple Sclerosis
When standard cancer treatments become limited, biomarker-driven oncology trials in China may offer new pathways for global patients. As a medical concierge provider, we handle the complex medical translation and site shortlisting.
Read the guide: https://zurl.co/u9k2s
#MedicalTourismChina #ClinicalTrials #Oncology #MedicalConcierge

Home > Blog > Advanced Therapies & TechnologyKey Takeaways β’ China's oncology trial landscape focuses heavily on biomarker-driven protocols, including ADCs, bispecific antibodies, and CAR-T therapies. β’ Access requires verified molecular evidence before trial-site shortlisting or outreach begins, rather than broad open enrollment. β’ Administrative barriers include language, residency rules, and complex hospital intake systems, necessitating professional coordination. β’ Official optimizatio
Novo Nordisk Data Breach Exposes Clinical Trial Information
A recent data breach at Novo Nordisk exposed sensitive clinical trial information, including pseudonymized patient records and healthcare provider contact details, highlighting the importance of robust data security measures. The breach serves as a cautionary tale, reminding us that even seemingly anonymized data can be vulnerable toβ¦
#ClinicalTrials #DataBreach #Healthcare #EmergingThreats #PseudonymizedData